Abstract:Background: Human induced pluripotent stem cells (hiPSCs) offer an unprecedented opportunity to generate a potentially unlimited source of cells to develop model systems that facilitate a mechanistic understanding of human disease. However, the predictive ability of hiPSC derived neurocardiac co-culture systems to recapitulate the human phenotype in diseased modelling is limited. Here, we optimized current methods for efficient and replicable induction of cardiac myocytes (hiPSC-CMs) and sympathetic neurons (hiPSC-SNs). The utility of healthy co-cultures was tested with pressor agents to develop a model of cardiac hypertrophy. Mono-cultures and co-cultures were also made from a patient with a catecholaminergic polymorphic ventricular tachycardia (CPVT) genotype (with isogenic pairing) to generate a model of triggered arrhythmia. Method: hiPSC-CMs and hiPSC-SNs were characterized by immunofluorescence, flow cytometry and calcium (Ca2+) imaging. Healthy hiPSC-CMs were incubated with angiotensin II (AngII) or endothelin-1 (ET-1) for 48 hours. Immunostaining, qPCR and ELISA were performed to measure cell size, pro-BNP expression and secretion in hypertrophic and control groups. cAMP was measured by Förster resonance energy transfer (FRET). Neurocardiac co-cultures were established by re-seeding spontaneously beating hiPSC-CMs (day 20) with mature hiPSC-SNs (day 40). Intracellular Ca2+ transients were measured in myocytes in response to isoprenaline, and in neurons in response to nicotinic stimulation. Results: Healthy hiPSC-SNs possessed neurite outgrowth, stained positive for PHOX2B, tyrosine hydroxylase and peripherin. Derived myocytes showed spontaneous beating, stained positive for cardiac troponin T and a-actinin. Cell surface area was significantly increased in older iPSC-CMs (day 40) (606.3±290.4μm2 vs 3299.8±967.9μm2, p<0.0001) compared to younger cells (day 20). Sarcomere length extended from 1.59μm to 1.88μm (p<0.0001). Healthy hiPSC-CMs exposed to AngII 0.1 μM (n=23), or ET-1 100nM (n=13) resulted in cell and nuclear enlargement, as well as enhanced proBNP gene expression and proBNP secretion. This overexpression was reversed by losartan in AngII treated cells. Cytoplasmic cAMP levels were increased by isoprenaline, which was higher in hypertrophic cells. CMs from the CPVT hiPSC line expressed a higher Ca2+ responsive to isoprenaline, caffeine and KCl stimulation when compared with healthy hiPSC-CMs. They also displayed spontaneous Ca2+ oscillations after isoprenaline. CPVT hiPSC-SNs had greater Ca2+ transients to nicotinic stimulation, indicating a diseased phenotype also resides in the neuron as well as the myocyte. Conclusion: We have recapitulated many features of the anatomy and (patho)physiology of SN and CM, where co-culture preparations behave in a manner that mimics key physiological responses seen in other mammalian systems. Whether our cell types have the full transcriptomic atlas of actual human cells remains to be established. CSC-COI Scholarship Programme, British Heart Foundation This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Human iPSC derived cardiac myocytes and sympathetic neurons in disease modelling

Abstract 58: Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells

Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome

Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions

Overexpression of KCNJ2 Enhances Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model

Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes

In vitro model of ischemic heart failure using human induced pluripotent stem cell–derived cardiomyocytes

Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues

Synergistic generation of cardiac resident-like macrophages and cardiomyocyte maturation in tissue engineered platforms

Human Neurons Form Axon-Mediated Functional Connections with Human Cardiomyocytes in Compartmentalized Microfluidic Chip

Computational Study of the Excitation of Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes

Electrophysiological and calcium-handling development during long-term culture of human-induced pluripotent stem cell-derived cardiomyocytes

Cardiac Myocytes Derived from Murine Reprogrammed Fibroblasts: Intact Hormonal Regulation, Cardiac Ion Channel Expression and Development of Contractility

Modelling neurocardiac physiology and diseases using human pluripotent stem cells: current progress and future prospects

Single-Cell RNA-Sequencing and Optical Electrophysiology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Discordance Between Cardiac Subtype-Associated Gene Expression Patterns and Electrophysiological Phenotypes

Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies

Contractility and Calcium Transient Maturation in the Human iPSC-Derived Cardiac Microfibers.

Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs. 3D engineered heart tissue

Abstract 439: Modeling Diabetic Cardiomyopathy Model Using Human Induced Pluripotent Stem Cell-derived Cardiomyocytes

Multimodal Mapping of Electrical and Mechanical Latency of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Layers